{"id":"W4361959809","doi":"10.1158/1078-0432.c.6529533","title":"Data from A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor–Positive Breast Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Astellas Pharma; Pfizer","keywords":"Enzalutamide; Medicine; Cohort; Exemestane; Internal medicine; Population; Breast cancer; Placebo; Clinical endpoint; Oncology; Gastroenterology; Endocrinology; Prostate cancer; Cancer; Randomized controlled trial; Androgen receptor; Aromatase; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003139199,0.001767403,0.003561395,0.000384522,0.000640584,0.001309429,0.0009136992,0.00173258,0.01289919],"category_scores_gemma":[0.003930842,0.0006193494,0.002916084,0.0006450615,0.001008433,0.001290347,0.0003959776,0.003407196,0.001797452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007206721,"about_ca_system_score_gemma":0.001928998,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009090538,"about_ca_topic_score_gemma":0.003082194,"domain_scores_codex":[0.9984742,0.0009503798,0.0001340753,0.0001707514,0.0001302541,0.0001404769],"domain_scores_gemma":[0.9972826,0.0008835972,0.0006463681,0.0002960088,0.0002632342,0.0006281243],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.970326,0.003897793,0.0007298259,0.001328939,0.002154086,0.00006079549,0.00003751107,0.0003372466,0.00249055,0.0001115397,0.004346327,0.01417944],"study_design_scores_gemma":[0.9643599,0.03021361,0.001853775,0.00008037673,0.001021735,0.00004036049,0.00001668639,0.0000960809,0.000296825,0.0001223124,0.001884912,0.00001329471],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.8857918,0.02974121,0.002421321,0.005394866,0.002998529,0.02045229,0.03585296,0.0003728604,0.01697413],"genre_scores_gemma":[0.9263682,0.0126584,0.003060534,0.006081372,0.001143685,0.0174015,0.02517536,0.0001053528,0.008005575],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.01289919,"threshold_uncertainty_score":0.04315209,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0627104037941062,"score_gpt":0.3842795352735436,"score_spread":0.3215691314794374,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}